terfenadine has been researched along with olopatadine hydrochloride in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (22.22) | 18.2507 |
2000's | 10 (55.56) | 29.6817 |
2010's | 4 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, RJ; Duddle, J; Hamilton, SA; Herdman, MJ; Trigg, CJ | 1 |
Ishii, H; Ohmori, K; Sasaki, Y | 1 |
Ichimura, M; Kato, Y; Mori, T; Ohmori, K | 1 |
Kato, Y; Masumiya, H; Shigenobu, K; Tanaka, H | 1 |
Abelson, MB; Berger, WE; D'Arienzo, PA; Granet, DB; Kägi, MK; Lanier, BQ; Spangler, DL | 1 |
Abelson, MB; Gotnes, PJ; Ober, A; Spangler, DL | 1 |
Hasegawa, Y; Hindmarch, I; Ishikawa, K; Kamei, H; Muraoka, I; Nabeshima, T; Noda, Y; Senzaki, K | 1 |
Iizuka, H; Ishida-Yamamoto, A; Takahashi, H | 1 |
Izu, K; Tokura, Y | 1 |
Aragane, Y; Ashenager, MS; Grgela, T; Kawada, A | 1 |
Morita, E; Takahashi, H; Zhang, Y | 1 |
Fukui, H; Izumi, N; Mizuguchi, H; Ogino, S; Umehara, H | 1 |
Cheng, L; Dake, Y; Enomoto, K; Enomoto, T; Ide, T; Lu, HQ; Sakoda, T; Yin, M | 1 |
Kimoto, N; Tamura, T | 1 |
Isaji, A; Ishikawa, K; Kamei, H; Nabeshima, T; Noda, Y; Senzaki, K; Sugiura, K; Tomita, Y; Yamada, K | 1 |
Kanda, T; Takizawa, F; Tamura, T; Yamada, K | 1 |
Ono, A; Sugano, K | 1 |
Kabashima, K; Miyachi, Y; Nakamizo, S; Otsuka, A; Tanizaki, H; Yamamoto, Y | 1 |
9 trial(s) available for terfenadine and olopatadine hydrochloride
Article | Year |
---|---|
Comparison of a new antihistaminic and antiallergic compound KW 4679 with terfenadine and placebo on skin and nasal provocation in atopic individuals.
Topics: Adult; Airway Resistance; Cross-Over Studies; Dibenzoxepins; Double-Blind Method; Female; Humans; Male; Nasal Provocation Tests; Olopatadine Hydrochloride; Placebos; Rhinitis, Allergic, Seasonal; Skin Tests; Sleep Stages; Sneezing; Terfenadine | 1994 |
Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge.
Topics: Administration, Intranasal; Administration, Topical; Adult; Allergens; Androstadienes; Anti-Allergic Agents; Anti-Inflammatory Agents; Conjunctivitis, Allergic; Dibenzoxepins; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Histamine H1 Antagonists; Humans; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Rhinitis, Allergic, Perennial; Terfenadine; Treatment Outcome | 2002 |
Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
Topics: Administration, Intranasal; Administration, Oral; Administration, Topical; Adult; Aged; Allergens; Anti-Allergic Agents; Conjunctiva; Conjunctivitis, Allergic; Dibenzoxepins; Double-Blind Method; Female; Humans; Male; Middle Aged; Mometasone Furoate; Nasal Mucosa; Olopatadine Hydrochloride; Ophthalmic Solutions; Pregnadienediols; Rhinitis, Allergic, Perennial; Tablets; Terfenadine; Time Factors | 2003 |
Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers.
Topics: Adult; Chlorpheniramine; Choice Behavior; Cognition; Cross-Over Studies; Dibenzoxepins; Double-Blind Method; Female; Flicker Fusion; Histamine H1 Antagonists; Humans; Male; Olopatadine Hydrochloride; Psychomotor Performance; Reaction Time; Terfenadine; Time Factors | 2003 |
Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Topics: Adult; Cetirizine; Cross-Over Studies; Dermatitis, Atopic; Dibenzoxepins; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Iontophoresis; Male; Olopatadine Hydrochloride; Piperidines; Psychomotor Performance; Pyridines; Sleep Stages; Terfenadine | 2004 |
Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
Topics: Adult; Cetirizine; Cross-Over Studies; Dibenzoxepins; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Histamine Antagonists; Humans; Iontophoresis; Male; Olopatadine Hydrochloride; Skin; Terfenadine; Urticaria | 2008 |
Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
Topics: Adult; Allergens; Cryptomeria; Dibenzoxepins; Double-Blind Method; Female; Follow-Up Studies; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Motor Activity; Olopatadine Hydrochloride; Pollen; Rhinitis, Allergic, Seasonal; Sleep; Sneezing; Terfenadine; Treatment Outcome | 2009 |
Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.
Topics: Adolescent; Dibenzoxepins; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Olopatadine Hydrochloride; Promethazine; Pruritus; Psychomotor Performance; Rhinitis, Allergic, Seasonal; Terfenadine; Urticaria; Young Adult | 2012 |
Comparison of the efficacy of olopatadine and fexofenadine in chronic idiopathic urticaria patients: a crossover study.
Topics: Adult; Anti-Allergic Agents; Chronic Disease; Cross-Over Studies; Dibenzoxepins; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Olopatadine Hydrochloride; Terfenadine; Treatment Outcome; Urticaria | 2015 |
9 other study(ies) available for terfenadine and olopatadine hydrochloride
Article | Year |
---|---|
[Effect of KW-4679, an antiallergic drug, on antigen-induced airway microvascular leakage in rats passively sensitized with mouse monoclonal IgE antibody].
Topics: Animals; Anti-Allergic Agents; Antibodies, Monoclonal; Antigens; Bronchial Provocation Tests; Capillary Permeability; Depression, Chemical; Dibenzoxepins; Dose-Response Relationship, Drug; Immunoglobulin E; Ketotifen; Male; Mice; Mice, Inbred BALB C; Olopatadine Hydrochloride; Rats; Rats, Inbred Strains; Terfenadine; Trachea | 1996 |
Effect of terfenadine and KW-4679, a novel antiallergic compound, on action potential of guinea pig ventricular myocytes.
Topics: Action Potentials; Animals; Anti-Allergic Agents; Dibenzoxepins; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Olopatadine Hydrochloride; Terfenadine | 1996 |
Inhibitory effects of terfenadine on the rising phase of action potentials and sinus rates in isolated guinea-pig myocardium.
Topics: Action Potentials; Animals; Anti-Allergic Agents; Depression, Chemical; Dibenzoxepins; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Male; Olopatadine Hydrochloride; Terfenadine | 1996 |
The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis.
Topics: Adult; Anti-Allergic Agents; Cetirizine; Dermatitis, Atopic; Dibenzazepines; Dibenzoxepins; E-Selectin; Female; Histamine H1 Antagonists; Humans; Imidazoles; Intercellular Adhesion Molecule-1; Male; Olopatadine Hydrochloride; Substance P; Terfenadine; Vascular Cell Adhesion Molecule-1 | 2005 |
Inhibition of cytokine-induced expression of T-cell cytokines by antihistamines.
Topics: Cells, Cultured; Cetirizine; Dibenzoxepins; Histamine H1 Antagonists, Non-Sedating; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-12; Interleukin-4; Interleukin-5; Loratadine; Olopatadine Hydrochloride; RNA, Messenger; T-Lymphocytes; Terfenadine | 2007 |
Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Butyrophenones; Cetirizine; Child; Chlorpheniramine; Dermatitis, Atopic; Dibenzazepines; Dibenzoxepins; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Imidazoles; Japan; Male; Middle Aged; Olopatadine Hydrochloride; Pain Measurement; Piperidines; Population Surveillance; Psychomotor Performance; Pyridines; Quality of Life; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sleep Stages; Surveys and Questionnaires; Terfenadine; Urticaria | 2008 |
Efficacy of repeated pretreatment with olopatadine hydrochloride on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
Topics: Administration, Intranasal; Animals; Anti-Allergic Agents; Dibenzoxepins; Disease Models, Animal; Drug Administration Schedule; Histamine H1 Antagonists, Non-Sedating; Male; Nerve Growth Factor; Olopatadine Hydrochloride; Rats; Rats, Inbred BN; Rhinitis, Allergic, Seasonal; Terfenadine; Toluene 2,4-Diisocyanate; Vascular Endothelial Growth Factor A | 2009 |
The effect of antihistamines on seizures induced by increasing-current electroshocks: ketotifen, but not olopatadine, promotes the seizures in infant rats.
Topics: Age Factors; Animals; Anti-Allergic Agents; Brain; Caffeine; Central Nervous System Stimulants; Dibenzoxepins; Electroshock; Epilepsy; GABA Antagonists; Histamine H1 Antagonists; Ketotifen; Male; Olopatadine Hydrochloride; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Terfenadine | 2012 |
Application of the BCS biowaiver approach to assessing bioequivalence of orally disintegrating tablets with immediate release formulations.
Topics: Administration, Oral; Animals; Biopharmaceutics; Chemistry, Pharmaceutical; Dibenzoxepins; Droxidopa; Famotidine; Humans; Hydrochlorothiazide; Olopatadine Hydrochloride; Pharmaceutical Vehicles; Tablets; Terfenadine; Therapeutic Equivalency | 2014 |